BRIEF-Novelion's Aegerion Pharmaceuticals enters into licensing agreement with Amryt Pharma - Raglan Capital

Home
About Us
Selected Transactions
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

BRIEF-Novelion’s Aegerion Pharmaceuticals enters into licensing agreement with Amryt Pharma

Home
2016
BRIEF-Novelion’s Aegerion Pharmaceuticals enters into licensing agreement with Amryt Pharma

Recent News

World’s first trial of deliberate coronavirus infection is approved
Scientists win approval to infect healthy volunteers with Covid for trial
Open Orphan gets final go-ahead for Covid-19 human trial
Covid-19: World’s first human challenge trials to start in UK
COVID-19: Volunteers to be exposed to virus in world-first study in UK
Open Orphan starts trials on nasal spray COVID-19 vaccines

BRIEF-Novelion's Aegerion Pharmaceuticals enters into licensing agreement with Amryt Pharma

Reuters, 5th December 2016

By Reuters Staff

https://www.reuters.com/article/idUSASC09LRA

Prev
Next

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences